IDEXX Laboratories Aktie
WKN: 888210 / ISIN: US45168D1046
05.06.2020 13:14:08
|
OPTI Medical Systems Gets CE Mark For OPTI SARS-CoV-2 RNA PCR Test Kit
(RTTNews) - OPTI Medical Systems Inc., a subsidiary of IDEXX Laboratories Inc. (IDXX), said that it has received the CE mark certification in the European Union for its OPTI SARS-CoV-2 RT-PCR laboratory test kit for the detection of SARS-CoV-2, the virus that causes COVID-19.
In addition, the FDA has granted Emergency Use Authorizatio for the new OPTI DNA/RNA Magnetic Bead Kit for nucleic acid extraction from respiratory samples to be used with the OPTI SARS-CoV-2 RT-PCR test kit, which enables OPTI Medical Systems to provide laboratories with a complete OPTI Medical Systems-manufactured workflow solution for COVID-19 testing.
The OPTI SARS-CoV-2 RT-PCR test kit uses real-time reverse transcription polymerase chain reaction (RT-PCR) technology and is designed to provide results in about 2-3.5 hours.

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu IDEXX Laboratoriesmehr Nachrichten
Analysen zu IDEXX Laboratoriesmehr Analysen
Aktien in diesem Artikel
IDEXX Laboratories | 344,60 | -2,30% |
|